Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_assertion type Assertion NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_head.
- NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_assertion description "[We found a statistically significantly increased risk of bladder cancer associated with the FASLG -844CC genotype adjusted OR=1.51; 95% CI 1.03-2.23 compared with -844 (CT+TT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_provenance.
- NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_assertion evidence source_evidence_literature NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_provenance.
- NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_assertion SIO_000772 16538171 NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_provenance.
- NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_assertion wasDerivedFrom gad-20130706 NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_provenance.
- NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_assertion wasGeneratedBy ECO_0000203 NP64530.RAh2gu1SwIKdfUetoRcSb3jkNAE4VHQ0abttEfjRbYlwk130_provenance.